Although GBM samples showed a trend of hypomethylation, there was no statistically significant difference in SMARCAL1 promoter methylation between tumor and normal groups (Fig. 4G), indicating that other regulatory mechanisms might influence its expression in GBM. Here, SMARCAL1 is linked to glioblastoma.